Clinical Performance of AH Plus Jet® Root Canal Sealers in Single-cone Protocols
Part of paid clinical trials in New York, New York.
- Sponsor
- Dentsply Sirona Implants and Consumables
- Study ID
- NCT07642284
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Root Canal Treatment
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- AH Plus Jet® Endodontic Sealer — DEVICEAH Plus® endodontic sealer is a class IIa medical device used for permanent obturation of root canals of teeth of the secondary dentition in combination with root canal points, for subjects in need of endodontic treatment to restore a tooth. AH Plus Jet® Endodontic Sealer has similar intended use and the same indications for use as the predicate Root Canal Sealer (AH Plus Jet® Root Canal Sealing Material). However, there are minor differences in the technological characteristics.
- AH Plus Jet® Root Canal Sealing Material — DEVICEAH Plus® endodontic sealer is a class IIa medical device used for permanent obturation of root canals of teeth of the secondary dentition in combination with root canal points, for subjects in need of endodontic treatment to restore a tooth. AH Plus Jet® Root Canal Sealing Material is a predicate to AH Plus Jet® Endodontic Sealer.
Study Details
A prospective, parallel-group, randomised, post-market clinical follow-up investigation evaluating the performance and safety of the modified formula of the AH Plus Jet® Endodontic Sealer (also referred to as ES) and the predicate AH Plus Jet® Root Canal Sealing material (also referred to as RCS). Around 150 teeth will be randomly assigned to receive either ES or RCS root canal treatment using the single-cone technique. A maximum of 2 teeth per subject will be included and "tooth" will be considered the statistical unit and hence considered independent even if they are in the same subject. They will be followed up for a period of 24 months to assess the outcomes.
Key Dates
- Start date
- May 30, 2026
- Status verified
- Jun 2026
- Primary completion
- Mar 30, 2028
- Completion
- Mar 30, 2029
Study Design
- Enrollment
- 130 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Investigation medical Device 1 (IMD1)Endodontic sealer material with a modified formula compared to the predicate.
- Active Comparator: Investigation medical Device 2 (IMD2)Predicate endodontic sealer material.
Primary Outcome Measure
Endodontic treatment success [ Time Frame: At 1 year after Root Canal Treatment (RCT) visit (RCT visit conducted a maximum 2 months after day 0). ]
Central Contacts
- Mikaela Friberg+46 702 644 357
- Ulrika Bonander+46 706 440 844
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| New York University College of Dentistry | New York | New York | 10010 | Matthew Malek |
Find similar trials in New York, NY
Related Studies
- Histological Evaluation in the Efficacy of GentleWave in Root Canal Pulp Tissue Debridement and Disinfection of Difficult to Reach Areas in Mandibular Human Molars II. An In-vivo Study.Not Yet Recruiting · The University of Texas Health Science Center, Houston · Houston, Texas